AMA, FICS coalition launch consumer flu site

Share this article:
The AMA partnered with the Flu Information Care System (FICS) – a coalition of pharmacies, drug makers, state governments, tech providers and others – to launch a flu assessment site for consumers.

The site will help patients determine the severity of their flu symptoms and share that information with a physician. Physicians will be able to use tools on the site to monitor their patients' symptoms, and manage patient flow within their respective practices. Mary Anne McCaffree, an AMA board member, said the site is the first step in a larger AMA web initiative that will provide additional online tools for patients and docs. As those tools are developed, new conditions outside of the flu will be added to a larger “umbrella portal,” according to an AMA spokesperson.

The flu site, AMAfluhelp.org, launched today and is powered by Healthy Circles, a personal health management destination that utilizes Microsoft's HealthVault technology for the storing of individual patient information. Consumers can take the flu assessment test on the site anonymously, or register to save and share information.
 
FICS industry partners, such as Merck, Epocrates and CVS/Caremark, will promote the site to physicians and consumers, but will not be able to advertise products or services through the site, according to the spokesperson. The state of Colorado is the first state to adopt the technology. Government health sites in Colorado will link directly to the AMA site, and put the system into practice today, Colorado medical representatives said on a press call.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...